According to a new market report published by Transparency Market Research “Pipeline Review of Glioblastoma Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2022,” the global glioblastoma treatment market was valued at USD 0.34 billion in 2013 and is estimated to reach USD 0.91 billion by 2022 at a CAGR of 11.4% from 2014 to 2022.
Browse the full Pipeline Review of Glioblastoma Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2022 report at http://www.transparencymarketresearch.com/pipeline-review-of-glioblastoma-treatment-market.html?
The global glioblastoma multiforme (GBM) treatment market is largely concentrated in the western countries of North America and Europe. These regions account for more than 60% of the market share. Majority of the GBM treatment drugs are initially approved in these regions, as the U .S. and Europe are most lucrative pharmaceutical markets. Early market entry, and high drug prices are the main factors driving growth of the GBM treatment market in the U.S. Rising diagnosis and treatment rates, and affordability of expensive medical treatments are other forces supporting the market in the U.S. and Europe. U.K. is the largest market for GBM treatment in Europe, followed by Germany, and France; while Spain accounts for the smallest share in the GBM treatment market. Although North America and Europe are currently the largest market segments, the compounded annual growth rate of the market in these regions is expected to be slower as compared to Asia Pacific. Various non-profit organizations such as American Brain Tumor Association, National Brain Tumor Society, Brain Tumor Foundation of Canada and others in the U.S. are involved in creating awareness regarding GBM diagnosis and treatment options to boost the market growth. Furthermore, approval of generic alternatives would impede the market growth and approval of new drugs would lead to substantial market growth.
India, China and Japan are major countries driving the GBM market in Asia Pacific. Japan is the second-largest individual pharmaceutical market, while India and China are the most populated countries resulting into large patient pool. These countries are also the two fastest growing economies globally. As these countries have a large low- and middle-income population, demand for low cost treatments is high. However, this trend is not likely in case of severe diseases such as GBM as the available treatments are limited and require higher cost.
The Rest of the World market comprises Latin America, Africa and the Middle East. Lack of awareness related to GBM, availability of advanced medical treatments and financial affordability are the major restraining forces in Latin American and African market. Overall it is expected that North America would lead the market throughout the forecast period, while Asia Pacific would be the fastest growing regional market in the GBM treatment market.
The pipeline review of glioblastoma treatment market has been segmented as below:
- Global Glioblastoma Treatment Market Revenue and Forecast, by Drugs
- Bevacizumab (Avastin)
- Temozolomide (Temodar and Temodal and Temcad)
- Carmustine (BiCNU)
- Global Glioblastoma Treatment Market Revenue and Forecast, by Geography
- North America
- Asia Pacific
- Rest of the World
- Global Pipeline Review of Glioblastoma Treatment
- Late Stage (Phase III)
- Rindopepimut (CDX-110)
- Early Stage (Phase I, II and Pre clinical)
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453